A fine addition: Finerenone in the evolving landscape of heart failure with preserved ejection fraction
Heart Fail Rev
.
2025 Mar;30(2):287-291.
doi: 10.1007/s10741-024-10462-2.
Epub 2024 Oct 30.
Authors
Rami Halaseh
1
,
Andrew J Sauer
2
3
,
Orly Vardeny
4
,
Mario Enrico Canonico
5
6
,
Josephine Harrington
6
7
,
Jana Svetlichnaya
8
,
Andrew P Ambrosy
9
10
Affiliations
1
Department of Medicine, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.
2
Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.
3
University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
4
Minneapolis VA Health Care System & University of Minnesota, Minneapolis, MN, USA.
5
Department of Advanced Biomedical Sciences, University of Naples, Naples, Italy.
6
CPC Clinical Research, University of Colorado, Denver, CO, USA.
7
Division of Cardiology, University of Colorado, Denver, CO, USA.
8
Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.
9
Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA. andrew.p.ambrosy@kp.org.
10
Division of Research, Kaiser Permanente Northern California, 4480 Hacienda Drive, Pleasanton, CA, USA. andrew.p.ambrosy@kp.org.
PMID:
39476221
DOI:
10.1007/s10741-024-10462-2
No abstract available
Keywords:
Finerenone; HFmrEF; HFpEF; Heart failure.
Publication types
Review